Chapter 6 Parasympathomimetics

Slides:



Advertisements
Similar presentations
INDIRECT CHOLINOMIMETICS Pharmacology Department
Advertisements

DIRECT CHOLINERGIC DRUGS Pharmacology Department
Direct cholinomimetic (Parasympathomimetics) Drugs
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 15 Cholinesterase Inhibitors and Their Use in Myasthenia Gravis.
Pharmacology of Cholinergic Agonists
INDIRECT CHOLINOMIMETICS
Copyright © 2014 by Mosby, an imprint of Elsevier Inc.
Pharmacology-1 PHL 313 Parasympathetic Nervous System Third Lecture By Abdelkader Ashour, Ph.D. Phone:
Pharmacology DOR 101 Abdelkader Ashour, Ph.D. 5 th Lecture.
预防医学系 刘玉梅 BEA Confidential. | 2 农药( pesticides )是指农业生产中用于消灭、 控制有害动植物(害虫、病菌、鼠类、杂草等) 和调节植物生长的各种药物, 并包括提高农药药效 的辅助剂、增效剂等. 农药按化学性质可分为:有机磷、氨基甲酸酯.
2.血管的神经支配 缩血管神经纤维 舒血管神经纤维 交感舒血管神经纤维 副交感舒血管神经纤维 脊髓背根舒血管神经纤维 血管活性肠肽神经元.
ANTICHOLINERGIC DRUGS Pharmacology Department
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.
Section 10. Nervous system Chapter 5. Drugs acting on nervous system
Cholinergic agonists & Cholinergic antagonists
Cholinergics, anticholinergics and antcholinesterases Nervous System Peripheral NS Sensory nerves Motor nerves Central NS (Brain and Spinal cord) Sensory.
Cholinergic agonists By Dr.Sajid Hussain
CHOLINERGIC AGONISTS.
ANTICHOLINERGIC DRUGS Prof. Alhaider Pharmacology Department Prof. Hanan Hagar Pharmacology Department.
Autonomic Nervous System Prof. Alhaider 1433 H Revision of Physiology and Anatomy What is the peripheral Nervous System? What is the differences between.
Autonomic Pharmacology 张纬萍 浙江大学医学院药理
Muscarinic receptor agonists. A Muscarinic receptor agonists §1. Choline esters ( 胆碱酯类 ) § Acetylcholine 乙酰胆碱 § Carbachol 卡巴胆碱 § Methacholine 醋甲胆碱 § Bethanechol.
DIRECT CHOLINERGIC DRUGS Prof. Hanan Hagar Pharmacology Department.
ANTICHOLINERGIC DRUGS Prof. Alhaider Pharmacology Department Prof. Hanan Hagar Pharmacology Department.
INDIRECT CHOLINOMIMETICS
Part 2 Parasympathomimetics
Chapter six BASIC PHARMACOLOGYOF THE DIRECT-ACTING CHOLINOCEPTOR STIMULANTS.
CHOLINOCEPTOR ACTIVATING DRUGS
Anticholinesterases 1. Reversible anticholinesterases
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 19 Cholinergic Drugs.
Pharmacology of the nervous system Shi-Hong Zhang ( 张世红 ), PhD Dept. of Pharmacology, School of Medicine, Zhejiang University
Cholinergic drugs.
Part 3 Cholinoceptor Antagonists. A Muscarinic receptor antagonists.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 20 Cholinergic Drugs.
DIRECT CHOLINERGIC DRUGS Profs. Abdalqader Alhaider & Hanan Hagar
ANTICHOLINERGIC DRUGS
ANTICHOLINERGIC DRUGS Prof. Alhaider Pharmacology Department Prof. Hanan Hagar Pharmacology Department.
第 7 章 抗胆碱酯酶药和 胆碱酯酶复活药. 抗 ChE 药作用原理: ChE 为 Ach 水解必需的酶 抗 ChE 药与它结合并使之失活 导致 Ach 在突触间隙大量蓄积 产生拟胆碱作用.
CHOLINERGIC TRANSMISSION
ANTICHOLINESTERASES Acetylcholinesterase is an enzyme that specifically cleaves acetylcholine to acetate and choline. It is located both pre-and post-synaptically.
Drugs Affecting the Autonomic Nervous System
Cholingeric Agonist Practice Questions. Pretest question The enzyme that is inhibited by echothiophate iodide isThe enzyme that is inhibited by echothiophate.
Cholinergic drugs.
Pawitra Pulbutr M.Sc. In Pharm (Pharmacology)
Autonomic drugs ( II ). Chapter 6 Cholinoceptor agonists and drugs affecting cholinesterase activity 胆碱受体激动药和作用于胆碱酯酶药 pay attention to action types and.
Chapter 18 Cholinoceptor Antagonists. Part A Muscarinic receptor antagonists.
INDIRECT CHOLINOMIMETICS Prof. Alhaider Pharmacology Department Prof. Hanan Hagar Pharmacology Department.
Dr: Samah Gaafar Al-shaygi بسم الله الرحمن الرحيم.
Autonomic Nervous System (ANS) Cholinergic Drugs 4 أ0م0د.وحدة بشير اليوزبكي.
Dr. Carl B. Goodman Professor of Pharmacology Florida A&M University College of Pharmacy & Pharmaceutical Sciences 308E FSH-SRC
Cholinergic (Cholinoceptor Activating) Drugs-1
INDIRECT CHOLINOMIMETICS Prof. Hanan Hagar Pharmacology Department.
INDIRECT CHOLINOMIMETICS Pharmacology Department
INDIRECT CHOLINOMIMETICS
inDirect Cholinomimetics
Autonomic nervous pharmacology 2
Pharmacology of the nervous system
Cholinesterase Inhibitors (Indirect acting cholinergic agonists)
School of Pharmacy, University of Nizwa
Neurotransmitters SOMATIC NERVOUS SYSTEM Striated ACh muscle
Cholinergic Agents 1.
School of Pharmacy, University of Nizwa
Adrenergic [ædrə‘nədʒik] agonists
Adrenergic antagonists
Chapter 6 Muscarinic [,mʌskə‘rinik]毒蕈碱的 receptor agonists
Anticholinergic drugs /‘ænti,kəuli’nə:dʒik/ 抗胆碱的
INDIRECT CHOLINOMIMETICS
SYMPATHETIC Increase BP & HR, glucose Perfusion to skeletal muscles Mydriasis, bronchodilatation PARASYMPATHETIC Miosis, decreased HR, BP, bronchia secretion,
inDirect Cholinomimetics
Cholinergic drugs.
Presentation transcript:

Chapter 6 Parasympathomimetics Cholinoceptor Agonists Anticholinesterases

Section1. M-R Agonists choline esters: 均含有季铵基团 acetylcholine (Ach):unstable, low selectivity methacholine (醋甲胆碱) carbachol (卡巴胆碱) bethanechol chloride (氯贝胆碱) alkaloids: pilocarpine muscarine arecoline (槟榔碱)

Effective in large dose iv Choline esters Acetylcholine (Ach,乙酰胆碱) [Pharmacological actions] Directly activate M, N-R muscarinic actions: in small dose nicotinic actions: in large dose Effective in large dose iv Local effect by im, sc

1. muscarinic actions (1) cardiovascular system Robert Furchgott 1. muscarinic actions (1) cardiovascular system vessel dilation, BP↓ (reflective HR↑) HR a. NO release↑ (M3 R →EDRF(NO) ↑→GC →cGMP↑→ intracellular Ca2+↓) b. NA release↓ Heart depression: atrium>ventricles negative (chronotropic, dromotropic, inotropic) effect Direct effect Negative feedback NA release ↓

mechanism of negative chronotropic effect ↓Ca2+ →↓automatic depolarization mechanism of negative dromotropic effect ↑ ERP of Atrioventricular node & Purkinje fibers →↓conduction mechanism of negative inotropic effect atrium: ↑ K+ efflux→ ↑ repolarization → action potential duration ↓ , ERP↓ ventricles: presynaptic membrane M-R →NA release↓

(2) splanchnic smooth muscle ① gastrointestinal tract: excitation motility increase; secretion stimulation ② urinary bladder: detrusor(逼尿肌) contraction trigone(三角区)and sphincter relaxation ③ bronchus: contraction

① glands secretion: increasingly ② eyes: (3) others ① glands secretion: increasingly ② eyes: miosis (iris sphincter contraction ) near vision (ciliary muscle contraction)

2. nicotinic actions (ganglion, skeletal muscle, adrenal medulla) NN-R: co-innervation and dominant theory adrenaline release NM -R: skeletal muscle contraction

Other choline esters Carbachol (卡巴胆碱): only used in glaucoma Methacholine (醋甲胆碱): xerosis of oral mucosa (口腔粘膜干燥症) Bethanechol (氯贝胆碱): abdominal distension, urinary retention

Alkaloids Pilocarpine(毛果芸香碱,匹鲁卡品) Muscarine(毒蕈碱) Arecoline (槟榔碱) Oxotremorine(震颤素) natural synthetic

Pilocarpine [Pharmacological actions]: selectively activate M-R 1. Eye Eyes and glands are particularly sensitive to this drug. It is primarily used in ophthalmology [Pharmacological actions]: selectively activate M-R 1. Eye miosis (pupiliary sphincter) decrease intraocular pressure spasm of accommodation (ciliary muscle) 2. Glands secretion: increase 3. Others

Circular muscle M-R Radial muscle α-R

Clinical uses 1.Glaucoma(青光眼) angle-closure glaucoma 1~2%, 4~8 h open-angle glaucoma 1~2%, 4~8 h 2.iritis(虹膜炎), iridocyclitis(虹膜睫状体炎) 3.others: dry mouth atropine poision

Adverse reactions Diarrhea Diaphoresis (出汗) Miosis Nausea Urinary urgency

流涎、流泪、恶心、呕吐、头痛、视觉障碍、腹部绞痛、腹泻、支气管痉挛、心动过缓和血压下降、休克 Muscarine 流涎、流泪、恶心、呕吐、头痛、视觉障碍、腹部绞痛、腹泻、支气管痉挛、心动过缓和血压下降、休克 捕蝇蕈 杯伞菌属 丝盖伞菌属

Section2 N-R agonists (nicotine, lobeline) Lobeline (洛贝林,山梗菜碱): respiratory center stimulants Nicotine:from tobacco Action: NM, NN, CNS and dependence (double phase: agonist and antagonist) Tobacco poison: Hypertension, Coronary heart disease, cancer, Cerebrovascular disease, Atherosclerosis, Peptic Ulcers

Section 3 Anticholinesterase Agents Cholinesterase (ChE) Common properties of anticholinesterase agents Reversible Anticholinesterase agents Irreversible Anticholinesterase agents

Cholinesterase(ChE) True Cholinesterase (acetylcholinesterase, AChE) (10 5 Ach / min ) Pseudocholinesterase (butyrylcholinesterase, BChE)

Common properties of anticholinesterase agents 药物与AChE形成的复合物水解速度慢 [Classifications] chemical structure non-covalent bonding agents: 依酚氯铵、他克林、多奈哌齐 carboxamide(氨甲酰类):毒扁豆碱、比斯的明、地美溴铵、利凡斯的明 Organophosphates properties Reversible Anticholinesterase agents Irreversible Anticholinesterase agents

[Pharmacological actions] 1. eye: like Pilocarpine 2. gastrointestinal tract (esophagus, stomach, intestine) e.g. Neostigmine can increase the motility (amplitude, frequency and tension)

4. glands secrete increasingly 3. neuromuscular junction of skeletal muscle (anti-AChE, neostigmine--excite receptor) 4. glands secrete increasingly 5. others (urinary tract, bronchia, cardiovascular system) Dominant theory, mainly negative effect

[Clinical Uses] 1. Myasthenia gravis (重症肌无力) 2. Postoperative abdominal distension; Urinary retention (! no mechanical obstruction ) 3.Glaucoma (毒扁豆碱、地美溴铵) 4. Intoxication of d-tubocurarine and cholinoceptor-blockers 5. Alzheimer’s disease 6. Supraventricular tachyarrhythmias

Myasthenia gravis A disease affecting skeletal muscle neuromuscular junctions. Frequent symptoms are ptosis(上睑下垂), diplopia(复视), difficulty in speaking and swallowing, and extremity weakness. Severe disease may affect all the muscles, including those necessary for respiration.

Neostigmine Pyridostigmine (吡斯的明) Ambenonium chloride (安贝氯胺) Galanthamin (加兰他敏)

Reversible Anticholinesterase agents Neostigmine (新斯的明) Skelatal muscle > GI、bladder smooth muscle > CV、Glands、eyes、brachial smooth muscle [Clinical Uses] po, sc, im (Not into CNS) 1. Myasthenia gravis: direct and indirect effects 2. Postoperative abdominal distension; Urinary retention 3. Intoxication of d-tubocurarine and atropine 4. Supraventricular tachyarrhythmias 5. glaucoma Cautions: Cholinergic Crisis (atropine, d-tubocurarine)

Physostigmine (毒扁豆碱 ) Clinical use: 1. Glaucoma Eyes: similar to pilocarpine (but more rapid, stronger and longer) Peripheral effects: similar to neostigmine but stronger Central effects: excitation→inhibition Clinical use: 1. Glaucoma 2. Intoxication of central anticholinergics (tricyclic antidepressant, antihistaminics, anti-emetic, antiparkinson agents, phenothiazines antipsychotic agents) 毒性大,除解毒外一般不全身应用

Other Reversible Anticholinesterase agents 1.Myasthenia gravis : neostigmine Pyridostigmine(吡斯的明) Ambenonium chloride(安贝氯铵 ) Galanthamine(加兰他敏 ) 2.Glaucoma: Physostigmine (1~2d) Demecarium bromide (地美溴铵, 9d ) 3.Alzheimer’s disease : Donepezil(多奈哌齐), Rivastigmine, Tacrine 4.Diagnostic test for myasthenia gravis : Edrophonium chloride(依酚氯铵,腾喜龙)

Edrophonium chloride 用于诊断重症肌无力和鉴别肌无力危象及胆碱能危 象。也用作筒箭毒碱等非去极化肌松剂的拮抗剂。 【用法及用量】 ①腾喜龙试验: iv 10mg,注射后重症肌无力症状明显缓解,10分钟后恢复原状,可确定诊断。 ②肌无力危象和胆碱能危象的鉴别:先注射2mg,若症状好转,再将其余8mg注射完,诊断为肌无力危象;若注射2mg后症状加重,应立即停注,诊断为胆碱能危象。 ③筒箭毒碱等非去极化肌松弛剂的拮抗剂:静脉注射5~10mg/次,总剂量可达40mg。

Irreversible Anticholinesterase Agents—Organophosphates(有机磷酸酯类) 1)弱:敌百虫、乐果、马拉硫磷 2)强:敌敌畏 3)剧:内吸磷、甲拌磷、对硫磷 4)强剧:沙林、塔朋、梭曼 (战争化学毒气) Pathway of intoxication

Mechanisms of intoxication aging

Signs of intoxication 1. Acute intoxication: acute cholinergic crisis (1) M manifestation (muscarinic effects ) (2) N manifestation (nicotinic effects) (3) CNS effects 2. Chronic intoxication

心率减慢、血压下降、缩瞳可不明显

[signs of acute intoxication] 1.Mild intoxication: M signs 2.Moderate intoxication: M+N signs 3.Severe intoxication: M+N +CNS sign

Prevention and treatment of intoxication Diagnosis: exposure, symptoms, AChE activity Prevention: important Treatment of acute intoxication 1. Decontamination: to prevent further absorption (gas mask, removal of clothing, gastric lavage) 2. Symptomatic treatment and antidotes (1) Atropine: atropinization (阿托品化) (2) Cholinesterase Reactivators 3. Maintenance of vital signs

gastric lavage (敌百虫) (敌敌畏) 2% NaHCO3, or 1% brine → MgSO4 !! Dipterex―――――→DDVP (敌百虫) (敌敌畏) ×NaHCO3

Cholinesterase Reactivators Pralidoxime chloride (PAM-Cl):氯解磷定 Mechanisms of action 磷酰化氯解磷定 氯解磷定 1. 复合物 磷酰化AChE AChE 2. Direct binding with free organophosphates therapeutic effect 1. inhibit Nm manifestation——strong 2. inhibit M manifestation——weak 3. CNS

PAM-Cl also have the followings: better water-solubility and stability little adverse reaction im, iv